Central Bank & Trust Co. lowered its stake in shares of The Allstate Co. (NYSE:ALL – Free Report) by 21.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 3,353 shares of the insurance provider’s stock after selling 935 shares during the period. Central Bank & Trust Co.’s holdings in Allstate were worth $646,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. FSA Wealth Management LLC bought a new position in Allstate during the third quarter valued at approximately $26,000. Northwest Investment Counselors LLC purchased a new stake in Allstate during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC bought a new position in shares of Allstate during the 3rd quarter valued at $29,000. Peoples Bank KS purchased a new position in shares of Allstate in the 4th quarter worth $49,000. Finally, Transamerica Financial Advisors Inc. bought a new stake in shares of Allstate in the third quarter worth $58,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Stock Down 1.2 %
ALL opened at $188.85 on Tuesday. The company has a market capitalization of $50.01 billion, a PE ratio of 12.23, a price-to-earnings-growth ratio of 1.35 and a beta of 0.52. The firm has a 50-day simple moving average of $195.73 and a two-hundred day simple moving average of $186.69. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 52 week low of $150.17 and a 52 week high of $209.88.
Allstate Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date of this dividend was Friday, November 29th. Allstate’s payout ratio is 23.83%.
Analyst Upgrades and Downgrades
ALL has been the topic of a number of recent research reports. Barclays lowered their target price on Allstate from $187.00 to $183.00 and set an “underweight” rating on the stock in a report on Monday, January 6th. Bank of America boosted their target price on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research report on Friday, October 18th. The Goldman Sachs Group increased their price target on shares of Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. Morgan Stanley boosted their price objective on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a research report on Thursday, November 7th. Finally, Evercore ISI upgraded Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $218.13.
Get Our Latest Research Report on ALL
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- How Can Investors Benefit From After-Hours Trading
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Stock Sentiment Analysis: How it Works
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How to Invest in Blue Chip Stocks
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.